ACE2 and infection: SARS-CoV-2 interacts with the angiotensin-converting enzyme 2 (ACE2) expressed by the nasal epithelia to enable the entry and infection of neighboring epithelial cells [1,2], while the conjunctival goblet cell is an alternative portal of entry [3,4].